Cargando…

Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer

Epidermal growth factor receptor (EGFR) and its ligands are involved in cancer pathogenesis. The emerging role of treatments co-targeting the EGFR system in breast cancer has increased the need to identify companion biomarkers. The aim of this study is to investigate whether pretreatment serum level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjær, Ina Mathilde, Olsen, Dorte Aalund, Brandslund, Ivan, Bechmann, Troels, Jakobsen, Erik Hugger, Bogh, Søren Bie, Madsen, Jonna Skov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538553/ https://www.ncbi.nlm.nih.gov/pubmed/33024132 http://dx.doi.org/10.1038/s41598-020-72944-1

Ejemplares similares

Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023)

New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer
por: Horn, Peer, et al.
Publicado: (2014)

Predicting brain metastases of breast cancer based on serum S100B and serum HER2
por: BECHMANN, TROELS, et al.
Publicado: (2013)

Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
por: Mojsoska, Biljana, et al.
Publicado: (2021)

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
por: Sørensen, Patricia Diana, et al.
Publicado: (2015)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Comparison of neurofilament light chain results between two independent facilities
por: Sejbaek, Tobias, et al.
Publicado: (2020)

Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations
por: Olsen, Dorte Aa., et al.
Publicado: (2020)

Serum vitamin K(1) associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes
por: Bøgh Andersen, Ida, et al.
Publicado: (2020)

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
por: Byg, Keld-Erik, et al.
Publicado: (2021)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
por: Nissen, Mette Scheller, et al.
Publicado: (2021)

Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy
por: Dunvald, Ann-Cathrine Dalgård, et al.
Publicado: (2023)

Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
por: Yao, Nan, et al.
Publicado: (2020)

Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling
por: Sugiyama, Michael G., et al.
Publicado: (2023)

Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology
por: Olsen, Dorte Aa., et al.
Publicado: (2021)

A Miniaturized Ligand Binding Assay for EGFR
por: Schwenk, Jochen M., et al.
Publicado: (2012)

BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
por: Fu, Wenyan, et al.
Publicado: (2019)

Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor
por: Roepstorff, Kirstine, et al.
Publicado: (2009)

Ligand-induced transmembrane conformational coupling in monomeric EGFR
por: Srinivasan, Shwetha, et al.
Publicado: (2022)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling
por: Bharde, Atul A., et al.
Publicado: (2013)

Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin
por: Coniglio, Salvatore J., et al.
Publicado: (2021)

ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion
por: Gnosa, Sebastian P., et al.
Publicado: (2022)

Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding
por: Wirth, Daniel, et al.
Publicado: (2023)

Malpractice litigation, workload, and general practitioner retirement
por: Birkeland, Søren, et al.
Publicado: (2019)

Aging and menopause reprogram osteoclast precursors for aggressive bone resorption
por: Møller, Anaïs Marie Julie, et al.
Publicado: (2020)

The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis
por: Lin, Chutong, et al.
Publicado: (2021)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2013)

Correction: Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling
por: Bharde, Atul A., et al.
Publicado: (2013)

Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels
por: Tatsumi, Manae, et al.
Publicado: (2023)

Sensitivity and performance of three novel quantitative assays of SARS-CoV-2 nucleoprotein in blood
por: Hillig, Thore, et al.
Publicado: (2023)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR(WT), EGFR(T790M), and EGFR(L858R))
por: Abo Al-Hamd, Mahmoud G., et al.
Publicado: (2023)

A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
por: Lee, Ki-Chang, et al.
Publicado: (2021)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

PGE(2)/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
por: Bazzani, Lorenzo, et al.
Publicado: (2017)

EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4crr7hdpn04us1g5b91e4tm0f1